Solid materials containing bisphenols require extraction releasing these endocrine disruptors before analysis - polycarbonate plastics, epoxy coatings, and thermal paper all harbor bisphenols needing specialized extraction for quantification. Bisphenol analysis with extraction addresses solid materials and complex matrices using GC-MS with derivatization for comprehensive detection following sample extraction. The extraction approach ensures complete recovery of free and bound bisphenols from various materials including polycarbonate where BPA comprises the polymer backbone, epoxy resins where bisphenols serve as curing agents, and thermal papers using bisphenols as color developers. Essential for validating BPA-free claims in medical devices demonstrating polycarbonate alternatives or coatings don't contain bisphenols, investigating endocrine disruption concerns when biological testing reveals estrogenic activity, and demonstrating compliance with expanding bisphenol restrictions across global markets. The extraction methodology releases bisphenols from polymer matrices through solvent extraction or thermal desorption, quantifies both monomeric bisphenols and oligomers that migrate during use, and accommodates various sample forms from powders to fabricated devices. For medical device materials, bisphenol testing validates that BPA-free formulations genuinely lack these compounds rather than containing structural analogs with similar endocrine activity. Manufacturing validation confirms processing doesn't introduce bisphenol contamination from equipment or additives, alternative materials marketed as BPA-free don't contain related bisphenols like BPS or BPF, and sterilization doesn't cause polymer degradation releasing bisphenols. The testing supports regulatory submissions demonstrating compliance with bisphenol restrictions, responds to customer requirements increasingly specifying bisphenol-free materials, and addresses stakeholder concerns about endocrine disruption from medical device exposure.